Which Growth Prospects will Transform the Global Pharmaceutical Industry?
2021 highlights and what to expect in 2022
Click image to view it in full size
The global pharmaceutical industry is witnessing dynamic trends amidst the coronavirus pandemic and is adapting to new challenges and opportunities. This study analyzes the 2021 highlights in the global pharmaceutical industry and provides forecasts for the next year and beyond, addressing the impact of innovative modalities, recent drug approvals, M&A, key regulatory and reimbursement updates, and technologies such as gene and cell therapy, monoclonal antibodies, RNA-based therapeutics and the increasing use of health data through real-world evidence and artificial intelligence.
Take your first step towards achieving growth-centric solutions with our
Growth Pipeline Dialog™. Speak to our industry experts in a complimentary open discussion that will spark innovative thinking and growth opportunities that will benefit your organization.
